CLNN

Clene (CLNN)

About Clene (CLNN)

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Details

Daily high

$5.77

Daily low

$5.36

Price at open

$5.55

52 Week High

$12.00

52 Week Low

$3.82

Market cap

44.3M

Dividend yield

0.00%

Volume

31,923

Avg. volume

91,956

P/E ratio

-23.49

Clene News